Cardiologists in Southampton have become the first in the UK to fit a patient with a revolutionary pill-sized pacemaker.
The wireless device, known as the Micra Transcatheter Pacing System, is the smallest in the world at one-tenth the size of traditional models and is implanted directly in the heart.
Currently, pacemakers are inserted under the skin and are connected to the heart with a lead that carries electrical signals to correct slow or irregular heartbeats. The new device, which is placed inside the wall of the heart by a catheter inserted through the groin, delivers electrical impulses from an electrode, removing the need for a lead to transmit signals.
“While pacemakers have saved countless thousands of lives over the past seven decades since the first devices were implanted, one of the major drawbacks has been complications related to the pacing lead that is put in to deliver electrical impulses to the heart,” explained Consultant Cardiologist Professor John Morgan, who performed the first two procedures with colleague Dr Paul Roberts as part of a clinical trial of the device at Southampton General Hospital.
“Now we have pacemakers that are so small - not much larger than an antibiotic pill - they can be attached directly to the inside of the heart, all the problems related to the old-fashioned pacemaker lead are abolished.”
Prof Morgan, who is also honorary chair in cardiac rhythm management at the University of Southampton, said the introduction of the device and launch of the study at Southampton General Hospital, which is the only trial centre in the UK, was a “landmark moment”.
He added: “In addition to the advantages of the device’s size and wireless technology, the procedure reduces the risk of infection and extended recovery time associated with traditional, more invasive surgical pacemaker implants.”
